Piezosurgery in the Treatment of Class II Furcation Involvement
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to evaluate the effectiveness of piezosurgery in the treatment of class II furcation involvement using biomaterials and new surgical techniques
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 5, 2014
CompletedFirst Posted
Study publicly available on registry
May 7, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedFebruary 10, 2017
February 1, 2017
1.6 years
May 5, 2014
February 9, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Horizontal probing depth (PH)
horizontal probing depth
180 days
Secondary Outcomes (5)
Plaque index (PI)
180 days
Bleeding on probing (BoP)
180 days
Pocket probing depth (PPD)
180 days
Furcation closure (FC)
180 days
Clinical attachment level (CAL)
180 days
Study Arms (3)
OFD with piezosurgery
EXPERIMENTALOpen flap debridement with Piezosurgery
OFD with piezosurgery+biomaterial
EXPERIMENTALOpen flap debridement with Piezosurgery with biomaterial mp3
OFD with piezosurgery+mp3+bracket
EXPERIMENTALOpen flap debridement with Piezosurgery with biomaterial mp3 + bracket
Interventions
Eligibility Criteria
You may qualify if:
- previous subgingival instrumentation with adequate plaque control (FMPS \< 20%) and bleeding on probing (FMBS \< 20%).
- one or more mandibular molar with buccal class-II furcation involvement
You may not qualify if:
- diabetes mellitus
- pregnancy and lactation period
- subjects smoking \> 10 cigarettes/day were excluded
- subjects in chronically treatment with calcium antagonist, immunosuppressive drugs and Antiepileptic Drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Matteo Visintinlead
Study Sites (1)
Matteo Visintin
Trieste, TS, 34100, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matteo Visintin
UCO Clinica Odontoiatrica e Stomatologica - Ospedale Maggiore Trieste
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Student
Study Record Dates
First Submitted
May 5, 2014
First Posted
May 7, 2014
Study Start
March 1, 2014
Primary Completion
October 1, 2015
Study Completion
November 1, 2017
Last Updated
February 10, 2017
Record last verified: 2017-02